Home › Companies › VOYAGER THERAPEUTICS INC. › 2023-2024

VOYAGER THERAPEUTICS INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and VOYAGER THERAPEUTICS INC.’s Form 8-K, filed 2024-06-06 (Item 5.07 on EDGAR). Page generated 02 October 2026.

5Ballot items
171Asset managers
1,087Fund votes
2024-06-05Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore VOYAGER THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by VOYAGER THERAPEUTICS INC.

These tallies are VOYAGER THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-06 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

VOYAGER THERAPEUTICS INC. — official shareholder meeting results, meeting held 2024-06-05
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Michael Higgins	30,865,370	--	--	6,932,691	8,600,728	Majority: yes
Elect Director: Jude Onyia, Ph.D.	34,864,862	--	--	2,933,199	8,600,728	Majority: yes
Elect Director: Nancy Vitale	31,262,994	--	--	6,535,067	8,600,728	Majority: yes
Voyager's stockholders approved a non-binding, advisory proposal regarding the compensation of Voyager's named executive officers.	35,949,375	1,711,367	137,319	--	8,600,728	Majority: yes
Voyager's stockholders ratified the appointment of Ernst & Young LLP as Voyager's independent registered public accounting firm for the fiscal year ending December 31, 2024.	46,278,029	72,375	48,385	--	--	Majority: yes

Source: VOYAGER THERAPEUTICS INC., Form 8-K, filed with the SEC on 2024-06-06 — read the filing on EDGAR.

How asset managers voted at the VOYAGER THERAPEUTICS INC. 2023-2024 meeting

Each item below shows how the 171 asset managers that disclosed a VOYAGER THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 11 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 35,949,375AGAINST: 1,711,367

VOYAGER THERAPEUTICS INC.’s own tally for this item (“Voyager's stockholders approved a non-binding, advisory proposal regarding the compensation of Voyager's named executive officers.”): 35,949,375 for, 1,711,367 against, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 54,393,628 outstanding shares: 66% for, 3% against (69% of the company cast a for/against vote).

The 171 asset managers below cast 93% of the shares they voted on this item FOR (29,299,384 for, 2,225,968 against).

FOR 93%7%

FOR: 29,299,384 (92.9%)AGAINST: 2,225,968 (7.1%)

Largest asset managers voting on “TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at VOYAGER THERAPEUTICS INC., 2023-2024
Asset manager	For	Against	Vote
EcoR1 Capital, LLC	3,917,546	0	For
BlackRock	3,484,605	6,296	For
ARMISTICE CAPITAL, LLC	3,340,670	0	For
Vanguard	3,236,834	0	For
State Street	2,695,646	4,952	For
FARALLON CAPITAL MANAGEMENT LLC	2,292,000	0	For
T. Rowe Price	1,853,988	0	For
American Century	0	1,580,918	Against
Federated Hermes	1,069,517	0	For
Dimensional	999,778	0	For
Fidelity	447,592	0	For
Vestal Point Capital, LP	440,517	0	For
GEODE CAPITAL MANAGEMENT, LLC	429,759	0	For
JPMorgan	304,375	0	For
GLOBEFLEX CAPITAL L P	284,908	0	For
AQR	274,793	0	For
FIDUCIARY TRUST CO	259,397	0	For
Northern Trust	245,302	0	For
Charles Schwab	228,904	0	For
ACADIAN ASSET MANAGEMENT LLC	197,458	0	For
Wellington	184,612	0	For
SEI	145,766	0	For
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0	140,300	Against
First Trust	138,916	0	For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	138,590	0	For

Showing the 25 largest of 171 asset managers. See all 171 in the interactive database.

2. To elect each of the following directors to serve as a Class III director until the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Jude Onyia

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%8%

FOR: 34,864,862WITHHELD: 2,933,199

VOYAGER THERAPEUTICS INC.’s own tally for this item (“Elect Director: Jude Onyia, Ph.D.”): 34,864,862 for, 2,933,199 withheld, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 54,393,628 outstanding shares: 64% for, 5% withheld (69% of the company cast a for/withheld vote).

The 61 asset managers below cast 100% of the shares they voted on this item FOR (9,522,540 for, 0 against).

FOR 83%ABSTAIN 17%

FOR: 9,522,540 (83.2%)ABSTAIN: 1,928,203 (16.8%)

Largest asset managers voting on “To elect each of the following directors to serve as a Class III director until the 2027 Annual Meeting of Sto” at VOYAGER THERAPEUTICS INC., 2023-2024
Asset manager	For	Abstain	Vote
Vanguard	3,153,151	0	For
BlackRock	2,169,021	0	For
State Street	23,970	976,508	Abstain
Dimensional	0	870,340	Abstain
T. Rowe Price	792,317	0	For
American Century	786,861	0	For
Federated Hermes	534,308	0	For
Fidelity	433,441	0	For
First Trust	138,916	0	For
MFS	138,590	0	For
BRIDGEWAY FUNDS INC	138,000	0	For
Charles Schwab	114,452	0	For
Direxion Shares ETF Trust	100,966	0	For
Equitable	96,012	0	For
TIAA	88,425	0	For
QUANTITATIVE MASTER SERIES LLC	73,364	0	For
SEI	72,883	0	For
AQR	70,179	0	For
WisdomTree	60,766	0	For
John Hancock	50,549	0	For
Lincoln Financial	12,122	31,537	Abstain
EA Series Trust	39,658	0	For
ALPS ETF Trust	38,353	0	For
Pacific Life	35,131	0	For
Putnam	0	32,025	Abstain

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

3. To elect each of the following directors to serve as a Class III director until the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Michael Higgins

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

82% Majority: yes · of votes cast

FOR 82%WITHHELD 18%

FOR: 30,865,370WITHHELD: 6,932,691

VOYAGER THERAPEUTICS INC.’s own tally for this item (“Elect Director: Michael Higgins”): 30,865,370 for, 6,932,691 withheld, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 54,393,628 outstanding shares: 57% for, 13% withheld (69% of the company cast a for/withheld vote).

The 61 asset managers below cast 100% of the shares they voted on this item FOR (8,707,034 for, 0 against).

FOR 76%ABSTAIN 24%

FOR: 8,707,034 (76.0%)ABSTAIN: 2,743,709 (24.0%)

Largest asset managers voting on “To elect each of the following directors to serve as a Class III director until the 2027 Annual Meeting of Sto” at VOYAGER THERAPEUTICS INC., 2023-2024
Asset manager	For	Abstain	Vote
Vanguard	3,153,151	0	For
BlackRock	2,169,021	0	For
State Street	986,092	14,386	For
Dimensional	0	870,340	Abstain
T. Rowe Price	792,317	0	For
American Century	0	786,861	Abstain
Federated Hermes	534,308	0	For
Fidelity	433,441	0	For
First Trust	0	138,916	Abstain
MFS	0	138,590	Abstain
BRIDGEWAY FUNDS INC	0	138,000	Abstain
Charles Schwab	114,452	0	For
Direxion Shares ETF Trust	0	100,966	Abstain
Equitable	71,282	24,730	For
TIAA	88,425	0	For
QUANTITATIVE MASTER SERIES LLC	73,364	0	For
SEI	72,883	0	For
AQR	0	70,179	Abstain
WisdomTree	0	60,766	Abstain
John Hancock	37,492	13,057	For
Lincoln Financial	26,300	17,359	For
EA Series Trust	0	39,658	Abstain
ALPS ETF Trust	0	38,353	Abstain
Pacific Life	35,131	0	For
Putnam	0	32,025	Abstain

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

4. To elect each of the following directors to serve as a Class III director until the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Nancy Vitale

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%WITHHELD 17%

FOR: 31,262,994WITHHELD: 6,535,067

VOYAGER THERAPEUTICS INC.’s own tally for this item (“Elect Director: Nancy Vitale”): 31,262,994 for, 6,535,067 withheld, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 54,393,628 outstanding shares: 57% for, 12% withheld (69% of the company cast a for/withheld vote).

The 61 asset managers below cast 100% of the shares they voted on this item FOR (8,749,042 for, 0 against).

FOR 76%ABSTAIN 24%

FOR: 8,749,042 (76.4%)ABSTAIN: 2,701,701 (23.6%)

Largest asset managers voting on “To elect each of the following directors to serve as a Class III director until the 2027 Annual Meeting of Sto” at VOYAGER THERAPEUTICS INC., 2023-2024
Asset manager	For	Abstain	Vote
Vanguard	3,153,151	0	For
BlackRock	2,169,021	0	For
State Street	986,092	14,386	For
Dimensional	0	870,340	Abstain
T. Rowe Price	792,317	0	For
American Century	0	786,861	Abstain
Federated Hermes	534,308	0	For
Fidelity	433,441	0	For
First Trust	0	138,916	Abstain
MFS	0	138,590	Abstain
BRIDGEWAY FUNDS INC	0	138,000	Abstain
Charles Schwab	114,452	0	For
Direxion Shares ETF Trust	0	100,966	Abstain
Equitable	96,012	0	For
TIAA	88,425	0	For
QUANTITATIVE MASTER SERIES LLC	73,364	0	For
SEI	72,883	0	For
AQR	0	70,179	Abstain
WisdomTree	0	60,766	Abstain
John Hancock	37,492	13,057	For
Lincoln Financial	26,300	17,359	For
EA Series Trust	0	39,658	Abstain
ALPS ETF Trust	0	38,353	Abstain
Pacific Life	35,131	0	For
Putnam	0	32,025	Abstain

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

5. To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%

FOR: 46,278,029AGAINST: 72,375

VOYAGER THERAPEUTICS INC.’s own tally for this item (“Voyager's stockholders ratified the appointment of Ernst & Young LLP as Voyager's independent registered public accounting firm for the fiscal year ending December 31, 2024.”): 46,278,029 for, 72,375 against, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 54,393,628 outstanding shares: 85% for, 0.2% against (85% of the company cast a for/against vote).

The 61 asset managers below cast 99.6% of the shares they voted on this item FOR (11,409,386 for, 41,357 against).

FOR 99.6%

FOR: 11,409,386 (99.6%)AGAINST: 41,357 (0.4%)

Largest asset managers voting on “To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm ” at VOYAGER THERAPEUTICS INC., 2023-2024
Asset manager	For	Against	Vote
Vanguard	3,153,151	0	For
BlackRock	2,169,021	0	For
State Street	998,779	1,699	For
Dimensional	870,340	0	For
T. Rowe Price	792,317	0	For
American Century	786,861	0	For
Federated Hermes	534,308	0	For
Fidelity	433,441	0	For
First Trust	138,916	0	For
MFS	138,590	0	For
BRIDGEWAY FUNDS INC	138,000	0	For
Charles Schwab	114,452	0	For
Direxion Shares ETF Trust	100,966	0	For
Equitable	96,012	0	For
TIAA	88,425	0	For
QUANTITATIVE MASTER SERIES LLC	73,364	0	For
SEI	72,883	0	For
AQR	70,179	0	For
WisdomTree	60,766	0	For
John Hancock	50,549	0	For
Lincoln Financial	43,659	0	For
EA Series Trust	0	39,658	Against
ALPS ETF Trust	38,353	0	For
Pacific Life	35,131	0	For
Putnam	32,025	0	For

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

Largest VOYAGER THERAPEUTICS INC. shareholders voting in 2023-2024

Ranked by the number of VOYAGER THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 54,393,628 shares outstanding at the time of that meeting.

Top VOYAGER THERAPEUTICS INC. shareholders by shares voted, 2023-2024
#	Asset manager	% of shares outstanding
1	EcoR1 Capital, LLC	7.20%
2	BlackRock	6.42%
3	ARMISTICE CAPITAL, LLC	6.14%
4	Vanguard	5.95%
5	State Street	4.96%
6	FARALLON CAPITAL MANAGEMENT LLC	4.21%
7	T. Rowe Price	3.41%
8	American Century	2.91%
9	Federated Hermes	1.97%
10	Dimensional	1.84%

Reported VOYAGER THERAPEUTICS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

VOYAGER THERAPEUTICS INC. beneficial owners on record for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
BlackRock	10.31%	13F
Vanguard Group	5.98%	13F
State Street	3.22%	13F
Dimensional Fund Advisors	2.03%	13F
T. Rowe Price	1.92%	13F
Geode Capital	1.79%	13F
AQR Capital	1.46%	13F
Morgan Stanley	1.10%	13F
Northern Trust	0.72%	13F
Goldman Sachs	0.55%	13F

Percentages above are of 54,393,628 shares outstanding, as reported by VOYAGER THERAPEUTICS INC. on its Form 10-Q dated 2024-05-08 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from VOYAGER THERAPEUTICS INC.’s 10-Q dated 2024-05-08. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At VOYAGER THERAPEUTICS INC.'s shareholder meeting held 2024-06-05, in the 2023-2024 proxy season, 171 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 1,087 separate fund positions. On the most widely held item on that ballot — TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE… — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: VOYAGER THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-06.

VOYAGER THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.